A number of factors, including microbiome analyses and the increased utilization of whole-genome sequencing in the clinical microbiology laboratory, has contributed to the explosion of novel prokaryotic species discovery, as well as bacterial taxonomy revision. This review attempts to summarize such changes relative to human clinical specimens that occurred in 2020 and 2021, per primary publication in the
International Journal of Systematic and Evolutionary Microbiology
or acceptance on Validation Lists published by the
International Journal of Systematic and Evolutionary Microbiology
.